TTR and amyloidosis: Compared with the transgenic mouse method (46, 47) that takes almost 2 years to develop cardiac deposits, our injection model can quickly generate the phenotype with an extensive display of ATTR-like deposits in the myocardium that likely resemble early events of amyloidosis.